Dental Pain (Following Third Molar Tooth Extraction) Study

• Status: Completed
• Trial end date: 2005-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effectiveness of GW406381 (a COX-2 inhibitor) in treating the signs and symptoms of dental pain following third molar tooth extraction.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion criteria:

• Scheduled for outpatient surgical removal of at least two third molar teeth.

Exclusion criteria:

• Subjects who do not achieve moderate to severe pain.

• Subjects who do not use acceptable contraception.

• Additional medical criteria will be assessed by the investigator.